CoChat

Assessment of serum‐free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study

Open access
Alexandraki, Krystallenia I., Kaltsas, Gregory A., Le Roux, Carel W., Fassnacht, Martin, Ajodha, Sharon, Christ‐Crain, Mirjam, Akker, Scott A., Drake, William M., Edwards, Ray, Allolio, Bruno, Grossman, Ashley B. · 2010 · Clinical Endocrinology
Cited by 29

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Objective Mitotane treatment in adrenocortical carcinoma (ACC) results in unreliable measurement of serum total cortisol (TC) levels because of an elevation in corticosteroid‐binding globulin (CBG). Design The use of a newly‐developed serum‐free cortisol (FC) assay was assessed to investigate the characteristics of a more valid measure of cortisol status. Patients Sixty‐two serum samples from patients with ACC treated with mitotane were studied. Different subgroups were studied according to mitotane levels (<14, 14–20 and >20 mg/dl), hydrocortisone replacement treatment, presence of Cushing’s syndrome (CS) and adrenocorticotrophin (ACTH) levels. Measurements Serum FC was measured using a newly‐developed assay, TC, CBG and plasma ACTH using conventional laboratory kits; TC‐to‐CBG (Free cortisol index, FCI, nmol/mg) and TC‐to‐FC (TFR) ratios were calculated. Results CBG levels were elevated and positively correlated to mitotane levels. FC was positively related to TC and FCI in nearly all subgroups studied. Plasma ACTH was negatively related to parameters of cortisol levels in the total samples studied. In the ‘target’ subgroup with normal ACTH levels and mitotane levels 14–20 mg/dl, no correlation of plasma ACTH with any parameter studied was seen, and FC suggested over‐replacement with hydrocortisone treatment in the subgroup with CS. Conclusions FC measurement may offer additional information in the follow‐up of patients on mitotane, especially when there is a history of CS which invalidates the use of acute changes in plasma ACTH as a parameter of hydrocortisone replacement. These preliminary data suggest that it may prove useful as a biochemical marker when TC or FCI are invalidated by mitotane treatment or plasma ACTH is suppressed by hypercortisolaemia. Larger studies are needed to substantiate the clinical utility of FC measurement in specific groups of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2009.03631.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 29

Metadata

Authors
Alexandraki, K. I., Kaltsas, G. A., Le Roux, C. W., Fassnacht, M., Ajodha, S., Christ‐Crain, M., Akker, S. A., Drake, W. M., Edwards, R., Allolio, B., & Grossman, A. B.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2010-02-10
Volume
72
Issue
3
Pages
305-311
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1974960405
Cited by
29
References
6
FWCI
2.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of serum‐free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. https://app.cochat.ai/papers/10.1111/j.1365-2265.2009.03631.x
The paper
Alexandraki, K. I., Kaltsas, G. A., Le Roux, C. W., Fassnacht, M., Ajodha, S., Christ‐Crain, M., Akker, S. A., Drake, W. M., Edwards, R., Allolio, B., & Grossman, A. B. (2010). Assessment of serum‐free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2009.03631.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.